a month ago
CABA
AnalystsDerek ArchilaDerek Archila's Stock Forecasts
AnalystsDerek Archila
Analyst Ranking
Top 1%
#21 out of 4174 analysts
Average Return
+45.82%
Win Rate
64%37 out of 58
Risk vs Reward
Poor
Good
Derek Archila's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Cabaletta Bio IncCABA | +1,308.47% | $0.87 | $12.31 | 2022-09-13 - 2023-02-03 | Strong Buy |
Prometheus Biosciences IncRXDX | +294.91% | $27.52 | $108.68 | 2022-05-12 - 2023-02-03 | Strong Buy |
Prometheus Biosciences IncRXDX | +185.97% | $33.50 | $95.80 | 2021-12-07 - 2022-12-07 | Strong Buy |
Ngm Biopharmaceuticals IncNGM | +167.08% | $11.30 | $30.18 | 2020-03-18 - 2021-03-19 | Strong Buy |
Rhythm Pharmaceuticals IncRYTM | +164.83% | $10.35 | $27.41 | 2021-12-07 - 2022-12-07 | Strong Buy |
Derek Archila Analyst Color
Get additional color on Derek Archila's coverage of popular stocks
a month ago
ASND
a month ago
IMVT
4 months ago
ARGX
5 months ago
ASND
5 months ago
RXDX
a year ago
ARGX
Derek Archila's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Kymera Therapeutics IncKYMR | 4 | Strong Buy | $42.00 | +13.06% | Maintains | a month ago |
Kezar Life Sciences IncKZR | 6 | Strong Buy | $14.00 | +97.18% | Maintains | a month ago |
Incyte CorpINCY | 3 | Hold | $75.00 | -10.30% | Maintains | a month ago |
Cabaletta Bio IncCABA | 3 | Strong Buy | $14.00 | +13.73% | Maintains | a month ago |
C4 Therapeutics IncCCCC | 3 | Hold | $9.00 | +30.25% | Maintains | a month ago |
Ascendis Pharma AASND | 6 | Strong Buy | $177.00 | +52.45% | Maintains | a month ago |
Apellis Pharmaceuticals IncAPLS | 3 | Hold | $58.00 | +5.90% | Downgrades | a month ago |
Arvinas IncARVN | 2 | Hold | $49.00 | +39.60% | Downgrades | a month ago |
Monte Rosa Therapeutics IncGLUE | 2 | Strong Buy | $19.00 | +131.43% | Upgrades | a month ago |
Blueprint Medicines CorpBPMC | 2 | Hold | $41.00 | -10.19% | Upgrades | a month ago |
Immunovant IncIMVT | 6 | Strong Buy | $27.00 | +52.11% | Upgrades | a month ago |
Horizon Therapeutics Public Ltd CoHZNP | 2 | Hold | $116.50 | +6.22% | Downgrades | 2 months ago |
Morphic Holding IncMORF | 4 | Strong Buy | $78.00 | +125.76% | Maintains | 3 months ago |
Argenx SeARGX | 3 | Strong Buy | $469.00 | +26.43% | Maintains | 4 months ago |
Prometheus Biosciences IncRXDX | 4 | Strong Buy | $71.00 | -34.67% | Maintains | 5 months ago |
Nurix Therapeutics IncNRIX | 3 | Strong Buy | $25.00 | +99.68% | Upgrades | 8 months ago |
Zentalis Pharmaceuticals IncZNTL | 1 | Strong Buy | $67.00 | +187.68% | Initiates Coverage On | 10 months ago |
Arena Pharmaceuticals IncARNA | 1 | Strong Buy | $71.00 | N/A | Initiates Coverage On | a year ago |
Rhythm Pharmaceuticals IncRYTM | 1 | Strong Buy | $30.00 | N/A | Initiates Coverage On | a year ago |
Esperion Therapeutics IncESPR | 1 | Hold | $20.00 | N/A | Downgrades | 2 years ago |
Lumos Pharma IncLUMO | 1 | Strong Buy | $24.00 | N/A | Upgrades | 2 years ago |
Momenta Pharmaceuticals IncMNTA | 2 | Hold | $52.50 | N/A | Downgrades | 2 years ago |
Principia Biopharma IncPRNB | 1 | Hold | $100.00 | N/A | Downgrades | 2 years ago |
Inventiva SaIVA | 1 | Strong Buy | $18.00 | N/A | Initiates Coverage On | 3 years ago |
Genfit SaGNFT | 1 | Strong Buy | N/A | N/A | Upgrades | 3 years ago |
Galapagos NvGLPG | 1 | Hold | $193.00 | N/A | Downgrades | 3 years ago |
Viela Bio IncVIE | 1 | Hold | $58.00 | N/A | Initiates Coverage On | 3 years ago |
Cymabay Therapeutics IncCBAY | 1 | Strong Buy | $8.00 | N/A | Upgrades | 3 years ago |
Oneok IncOKE | 1 | Strong Buy | $41.00 | N/A | Reiterates | 3 years ago |
Amarin Corp PLCAMRN | 2 | Hold | $8.00 | N/A | Maintains | 3 years ago |
Ngm Biopharmaceuticals IncNGM | 1 | Strong Buy | $32.00 | N/A | Maintains | 3 years ago |
Dbv Technologies SaDBVT | 2 | Hold | $6.00 | N/A | Downgrades | 3 years ago |
Vanda Pharmaceuticals IncVNDA | 4 | Hold | $29.00 | N/A | Downgrades | 4 years ago |
Heron Therapeutics IncHRTX | 2 | Buy | $50.00 | N/A | Maintains | 5 years ago |
Urogen Pharma LtdURGN | 1 | Buy | $51.00 | N/A | Maintains | 5 years ago |
Perrigo Co PLCPRGO | 1 | Buy | $88.00 | N/A | Initiates Coverage On | 5 years ago |
Pacira Biosciences IncPCRX | 1 | Hold | N/A | N/A | Initiates Coverage On | 5 years ago |
Zynerba Pharmaceuticals IncZYNE | 1 | Hold | N/A | N/A | Downgrades | 5 years ago |
Teva Pharmaceutical Industries LtdTEVA | 1 | Hold | N/A | N/A | Downgrades | 6 years ago |
©2023 WallStreetZen
Company
AboutBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.